Novartis
NVS
NVS
1,128 hedge funds and large institutions have $20.7B invested in Novartis in 2020 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 408 increasing their positions, 421 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
0% less funds holding
Funds holding: 1,133 → 1,128 (-5)
3% less repeat investments, than reductions
Existing positions increased: 408 | Existing positions reduced: 421
50% less funds holding in top 10
Funds holding in top 10: 30 → 15 (-15)
Holders
1,128
Holding in Top 10
15
Calls
$203M
Puts
$108M
Top Buyers
| 1 | +$293M | |
| 2 | +$59.9M | |
| 3 | +$53.8M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$49.5M |
| 5 |
Neuberger Berman Group
New York
|
+$37.7M |
Top Sellers
| 1 | -$313M | |
| 2 | -$159M | |
| 3 | -$93.2M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$66.5M |
| 5 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$61.6M |